Conagen develops high-purity vitamin K2 MK-7 with fermentation platform --- promising more MKs.
Conagen’s fermentation platform expands on promising novel forms of vitamin K2
31 oct. 2022 05h38 HE | Conagen
Bedford, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Biotech innovator, Conagen announced the development of its fermentation-derived vitamin K2 - a high-purity all-trans menaquinone-7 (MK-7).  This is...